Jade Biosciences Inc JBIO Q1 2026 Earnings EPS Miss Amid Continued PreRevenue Phase DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Pipeline Advances Telus Q1 2026 Earnings EPS Beat on Margin Discipline Despite Subdued Revenue Environment BRN Q4 2024 Earnings Loss Reported Amid Challenging Energy Environment Upstream Bio Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress CTNT Q1 2026 Earnings EPS Beats Estimates Despite Negative Earnings Stock Drops